RareCan: Funding, Investors & Team (Sep 2026)
RareCan is an organization set up for the purpose of speeding up research and ultimately improving outcomes for people with rarer forms of cancer.
RareCan has raised $300k across 1 funding round on record, the most recent a Seed of $300k announced in Mar 2021.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
RareCan Company Profile and Key Stats
Latest funding round on record: Mar 2021.
RareCan Funding Rounds
RareCan Founders and Leadership Team
Contact details for the RareCan team: 1 of 1 has an email address on file.
Start 14-day free trial →RareCan Funding Compared to Other Health Care Startups
RareCan's latest round of $300k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RareCan in Health Care and Hexham
Companies Similar to RareCan
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
RareCan Funding FAQs
What does RareCan do?
RareCan is an organization set up for the purpose of speeding up research and ultimately improving outcomes for people with rarer forms of cancer.
How much funding has RareCan raised?
RareCan has raised $300k across 1 round on record. The most recent is a Seed of $300k announced in Mar 2021.
When did RareCan last raise funding?
RareCan's most recent funding round on record is a Seed of $300k, announced in Mar 2021.
Who is the CEO of RareCan?
Piers Kotting is listed as CEO at RareCan.
Where is RareCan headquartered?
RareCan is based in Hexham, Northumberland, United Kingdom.
How many employees does RareCan have?
RareCan is in the 1-10 employee band.
How does RareCan's funding compare to other Health Care startups?
RareCan's latest round of $300k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's RareCan Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RareCan is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.